Serotoninergic modulation of cell volume response to estramustine: an image-analysis study on perifused individual glioma cells.
A technique of microscopy with computerised detection of early morphological changes during continuous perifusion was used to monitor the geometry changes of cultured glioma cells (MG-251) when exposed to 40 mg/L estramustine phosphate (EMP) alone or in combination with granisetron (0.1 mumol/L), ondansetron (0.1 mumol/L), or serotonin (1 mumol/L). When the cells were exposed to EMP, cell volume measured as projected cell area (PCA) rapidly increased. Serotonin and ondansetron, but not granisetron, prevented the acute EMP response (PCA). Serotonin, but none of the 5-HT3 receptor antagonists, protected against the cytotoxicity of EMP to the glioma cells as measured by a fluorometric microculture assay. Our results demonstrate hitherto unknown differences between selective 5-HT3 receptor antagonist on the cellular response to EMP and shows the necessity to study the receptor antagonists from viewpoint of interference with the antitumour drug effects on malignant cells. The perifusion technique could be used to study the effects of serotoninergic agonists and antagonists on cell volume regulation of cells exposed to anticancer drugs.
Behnam-Motlagh
P
P
Department of Clinical Chemistry, Umeå University Hospital, Sweden.
Engström
K G
KG
Henriksson
R
R
Grankvist
K
K
D048429:Cell Size / Q000187:drug effects; D004338:Drug Combinations; D004347:Drug Interactions; D004961:Estramustine / Q000494:pharmacology*; D005910:Glioma / Q000378:metabolism / Q000473:pathology*; D017829:Granisetron / Q000494:pharmacology*; D006801:Humans; D017294:Ondansetron / Q000494:pharmacology*; D012701:Serotonin / Q000494:pharmacology*; D012702:Serotonin Antagonists / Q000494:pharmacology*; D014407:Tumor Cells, Cultured
D004338:Drug Combinations; D004961:Estramustine; D017829:Granisetron; D017294:Ondansetron; D012701:Serotonin; D012702:Serotonin Antagonists